Burden of rare variants in arrhythmogenic cardiomyopathy with right dominant form‐associated genes provides new insights for molecular diagnosis and clinical management

Arrhythmogenic cardiomyopathy with right dominant form (ACR) is a rare heritable cardiac cardiomyopathy disorder associated with sudden cardiac death. Pathogenic variants (PVs) in desmosomal genes have been causally related to ACR in 40% of cases. Other genes encoding nondesmosomal proteins have been described in ACR, but their contribution in this pathology is still debated. A panel of 71 genes associated with inherited cardiopathies was screened in an ACR population of 172 probands and 856 individuals from the general population. PVs and uncertain significance variants (VUS) have been identified in 36% and 18.6% of patients, respectively. Among the cardiopathy‐associated genes, burden tests show a significant enrichment in PV and VUS only for desmosomal genes PKP2 (plakophilin‐2), DSP (desmoplakin), DSC2 (desmocollin‐2), and DSG2 (desmoglein‐2). Importantly, VUS may account for 15% of ACR cases and should then be considered for molecular diagnosis. Among the other genes, no evidence of enrichment was detected, suggesting an extreme caution in the interpretation of these genetic variations without associated functional or segregation data. Genotype–phenotype correlation points to (1) a more severe and earlier onset of the disease in PV and VUS carriers, underlying the importance to carry out presymptomatic diagnosis in relatives and (2) to a more prevalent left ventricular dysfunction in DSP variant carriers.

[1]  F. Ruschitzka,et al.  Impact of Genetic Variant Reassessment on the Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy Based on the 2010 Task Force Criteria. , 2020, Circulation. Genomic and precision medicine.

[2]  R. Redon,et al.  Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls , 2020, Genetics in medicine : official journal of the American College of Medical Genetics.

[3]  P. Munroe,et al.  State of the Art Review on Genetics and Precision Medicine in Arrhythmogenic Cardiomyopathy , 2020, International journal of molecular sciences.

[4]  H. Calkins,et al.  The role of genetics in cardiovascular disease: arrhythmogenic cardiomyopathy. , 2020, European heart journal.

[5]  M. Link,et al.  2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. , 2019, Heart rhythm.

[6]  Brandon K. Fornwalt,et al.  Prevalence and Electronic Health Record-based Phenotype of Loss-of-function Genetic Variants in Arrhythmogenic Right Ventricular Cardiomyopathy-associated Genes. , 2019, Circulation. Genomic and precision medicine.

[7]  H. Calkins,et al.  Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo: Segregation and Haplotype Analysis of a Multinational Cohort. , 2019, Circulation. Genomic and precision medicine.

[8]  P. Syrris,et al.  Heart failure in patients with arrhythmogenic right ventricular cardiomyopathy: Genetic characteristics. , 2019, International journal of cardiology.

[9]  M. Olesen,et al.  Reevaluation of genetic variants previously associated with arrhythmogenic right ventricular cardiomyopathy integrating population‐based cohorts and proteomics data , 2019, Clinical genetics.

[10]  M. Horie,et al.  Left-Dominant Arrhythmogenic Cardiomyopathy With Heterozygous Mutations in DSP and MYBPC3. , 2019, Circulation. Cardiovascular imaging.

[11]  J. Svendsen,et al.  Rare non-coding Desmoglein-2 variant contributes to Arrhythmogenic right ventricular cardiomyopathy. , 2019, Journal of molecular and cellular cardiology.

[12]  Michael D. Bordo,et al.  International Evidence , 2019, Corporate Financial Distress, Restructuring, and Bankruptcy.

[13]  Ryan L. Collins,et al.  Variation across 141,456 human exomes and genomes reveals the spectrum of loss-of-function intolerance across human protein-coding genes , 2019, bioRxiv.

[14]  H. Calkins,et al.  Diagnostic and therapeutic strategies for arrhythmogenic right ventricular dysplasia/cardiomyopathy patient , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[15]  R. Bellazzi,et al.  CardioVAI: An automatic implementation of ACMG‐AMP variant interpretation guidelines in the diagnosis of cardiovascular diseases , 2018, Human mutation.

[16]  R. Frank,et al.  Clinical Diagnosis, Imaging, and Genetics of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: JACC State-of-the-Art Review. , 2018, Journal of the American College of Cardiology.

[17]  Risha Govind,et al.  CardioClassifier: disease- and gene-specific computational decision support for clinical genome interpretation , 2018, Genetics in Medicine.

[18]  Quan Li,et al.  InterVar: Clinical Interpretation of Genetic Variants by the 2015 ACMG-AMP Guidelines. , 2017, American journal of human genetics.

[19]  W. Chung,et al.  Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics , 2016, Genetics in Medicine.

[20]  James Y. Zou Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.

[21]  Matthew S. Lebo,et al.  Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. , 2016, American journal of human genetics.

[22]  Heidi L Rehm,et al.  ClinGen--the Clinical Genome Resource. , 2015, The New England journal of medicine.

[23]  Stefan L. Zimmerman,et al.  Clinical Presentation, Long-Term Follow-Up, and Outcomes of 1001 Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Patients and Family Members , 2015, Circulation. Cardiovascular genetics.

[24]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[25]  Anne Cambon-Thomsen,et al.  Developing a guideline to standardize the citation of bioresources in journal articles (CoBRA) , 2015, BMC Medicine.

[26]  R. Hauer,et al.  Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy , 2012, European journal of heart failure.

[27]  R. Hauer,et al.  Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise. , 2011, Journal of the American College of Cardiology.

[28]  G. Danieli,et al.  Multiple mutations in desmosomal proteins encoding genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. , 2010, Heart rhythm.

[29]  N. Protonotarios,et al.  Naxos disease and Carvajal syndrome: cardiocutaneous disorders that highlight the pathogenesis and broaden the spectrum of arrhythmogenic right ventricular cardiomyopathy. , 2004, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[30]  D. Corrado,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: , 2004, Journal of cardiovascular electrophysiology.

[31]  Maurizio Schiavon,et al.  Does sports activity enhance the risk of sudden death in adolescents and young adults? , 2003, Journal of the American College of Cardiology.

[32]  R Frank,et al.  Right Ventricular Dysplasia: A Report of 24 Adult Cases , 1982, Circulation.